Solarin Becomes New President of Industrial Pharmacy Section of FIP

2
606
pharmacy

The International Pharmaceutical Federation (FIP) has appointed Pharm. Sola Solarin as the new president of Industrial Pharmacy Section (IPS) to coordinate the affairs of the federation for the next four years.

FIP is the global body representing over 4 million pharmacists and pharmaceutical scientists. It is a non-governmental organisation that has been in official relations with the World Health Organization (WHO) since 1948.

Pharm. Sola Solarin

According to the letter announcing his appointment, the former president, Ulf Janzon resigned and Michael Anisfeld finished his term as the secretary of the Industrial Pharmacy Section (IPS) and election was conducted to fill the IPS executive vacancies.

Paul Sinclair, board chair of pharmaceutical practice noted that Solarin is a former National Chairman of NAIP and has made many valuable contributions to FIP in various capacities over the years.

READ
Sex Workers Seek End to Harassment, Extortion by Security Operatives

He added that the new IPS executives will last for four years, the secretary will be Igor de Castro, the treasurer -Gabrielle (Gaby) Wiederkeh and Didier Mouliom will remain the vice-president.

Pharm. Solarin holds a Bachelor of Pharmacy degree from Obafemi Awolowo University, Ile-Ife, and an MBA from Institute of Graduate Management Education (IESE) in Spain. He was for two years the National Chairman of the Nigerian Association of Industrial Pharmacists and served as the Vice-President of IPS-FIP for seven years.

His career path was mainly in the areas of marketing and product development. He is presently the Managing Partner of Savante Consulting Ltd., Nigeria’s largest regulatory affairs consultancy.

READ
Highlights of the OAU Pharmacy Alumni Conference (Video)

Sinclair welcomes the new members and look forward to the participation of the president and secretary at the upcoming BPP meetings in January and March.

 

 

 

 

2 COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here